re: new product to launch In this project we have made some very significant steps forward in the evaluation of chicken cytokines as
alternative therapeutics. We have established proof-of-principal by showing that ChIFN-ã is a growth
promoter and immunoenhancer under commercial conditions. The next step will be to make this
technology available to Australian poultry producers as soon as possible. Infact, an Australian poultry
health company is currently negotiating with CSIRO for a licence to develop ChIFN-ã technology to
the Australian poultry market.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.050(11.8%) |
Mkt cap ! $81.26M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 34.5¢ | $736.2K | 2.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 17280 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 81123 | 10 |
View Market Depth
| Last trade - 12.52pm 16/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |